Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Assets (2016 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed Return on Assets for 15 consecutive years, with 0.06% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 7.0% to 0.06% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.06% through Dec 2025, up 7.0% year-over-year, with the annual reading at 0.06% for FY2025, 7.0% up from the prior year.
  • Return on Assets hit 0.06% in Q4 2025 for Ani Pharmaceuticals, up from 0.03% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.06% in Q4 2025 to a low of 0.09% in Q3 2022.
  • Historically, Return on Assets has averaged 0.02% across 5 years, with a median of 0.02% in 2024.
  • Biggest five-year swings in Return on Assets: increased 11bps in 2023 and later dropped -6bps in 2025.
  • Year by year, Return on Assets stood at 0.07% in 2021, then rose by 7bps to 0.06% in 2022, then skyrocketed by 133bps to 0.02% in 2023, then plummeted by -169bps to 0.01% in 2024, then soared by 482bps to 0.06% in 2025.
  • Business Quant data shows Return on Assets for ANIP at 0.06% in Q4 2025, 0.03% in Q3 2025, and 0.01% in Q2 2025.